TY - JOUR AU - de Andrés-Nogales, Fernando AU - Cruz, Encarnación AU - Calleja, Miguel Ángel AU - Delgado, Olga AU - Gorgas, Maria Queralt AU - Espín, Jaime AU - Mestre-Ferrándiz, Jorge AU - Palau, Francesc AU - Ancochea, Alba AU - Arce, Rosabel AU - Domínguez-Hernández, Raquel AU - Casado, Miguel Ángel PY - 2021 DO - 10.1186/s13023-021-01809-1 UR - http://hdl.handle.net/10668/3943 T2 - Orphanet Journal of Rare Diseases AB - Background: Patient access to orphan medicinal products (OMPs) is limited and varies between countries, reim‑bursement decisions on OMPs are complex, and there is a need for more transparent processes to know which criteria should be considered to... LA - en PB - BioMed Central KW - Multicriteria decision analysis KW - Orphan drugs KW - Rare diseases KW - Reimbursement KW - Spain KW - Técnicas de apoyo en la toma de decisiones KW - Medicamento huérfano KW - Enfermedades raras KW - Mecanismo de reembolso KW - España KW - Medical Subject Headings::Health Care::Health Care Economics and Organizations::Economics::Costs and Cost Analysis::Cost-Benefit Analysis KW - Medical Subject Headings::Psychiatry and Psychology::Psychological Phenomena and Processes::Mental Processes::Thinking::Decision Making KW - Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans KW - Medical Subject Headings::Humanities::Humanities::Philosophy::Life::Quality of Life KW - Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Rare Diseases KW - Medical Subject Headings::Geographical Locations::Geographic Locations::Europe::Spain KW - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Decision Support Techniques KW - Medical Subject Headings::Technology and Food and Beverages::Technology, Industry, and Agriculture::Industry::Drug Industry::Orphan Drug Production TI - A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study) TY - research article ER -